ARP products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Rawat · Pakistan
Islamabad/Rawat pharmaceutical manufacturer with a fully licensed manufacturing facility and nationwide sales and support network.
ARP products in Pakistan
ARP (PVT) Limited has 84 medicine presentations registered in Pakistan under 33 brands, covering 31 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Araxone (Ceftriaxone), Arixime (Cefixime), Arepine (Quetiapine) and Esitil (Escitalopram). 84 products have an official DRAP price on MedInfoBase. See all 33 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- ARP (Pvt.) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 12 & 12A, Street W-3, National Industrial Zone (RCCI), Rawat, Islamabad, Pakistan
- Website
- arp.com.pk ↗
- Phone
- +92 51 4499103
- info@arp.com.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where ARP (PVT) Limited is priced against the market
81 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Acidease 40mg InjectionRegistry verified | Esomeprazole as sodium | — | — | — | 111839Official source ↗ | No indexed price | — | — |
| Antibac-Skin | Mupirocin | 2% | Cream | 15g | 079491 | PKR 245.00 | PKR 16.33/g | 🔒 Pharma Pro |
| Aramox | Moxifloxacin | 400 mg | Tablet | 1x5s | 079462 | PKR 786.82 | PKR 157.36/tablet | 🔒 Pharma Pro |
| Arapime 1gm Injection IV/IMRegistry verified | Cefepime (as HCl)(with L-Arginine) | — | — | — | 062941Official source ↗ | No indexed price | — | — |
| Arapime 500mg Injection IV/IMRegistry verified | Cefepime (as HCl)(with L-Arginine) | — | — | — | 062940Official source ↗ | No indexed price | — | — |
| Arataxime | Cefotaxime | 250 mg | Injection | 1s | 062948 | PKR 99.39 | PKR 99.39/vial/unit | 🔒 Pharma Pro |
| Arataxime | Cefotaxime | 500 mg | Injection | 1s | 062949 | PKR 197.19 | PKR 197.19/vial/unit | 🔒 Pharma Pro |
| Arataxime | Cefotaxime | 1 g | Injection | 1s | 062950 | PKR 286.80 | PKR 286.80/vial/unit | 🔒 Pharma Pro |
| Araxone | Ceftriaxone | 250 mg | Injection | 1s | 062942 | PKR 167.31 | PKR 167.31/vial/unit | 🔒 Pharma Pro |
| Araxone | Ceftriaxone | 500 mg | Injection | 1s | 062943 | PKR 304.74 | PKR 304.74/vial/unit | 🔒 Pharma Pro |
| Araxone | Ceftriaxone | 1 g | Injection | 1s | 062944 | PKR 531.72 | PKR 531.72/vial/unit | 🔒 Pharma Pro |
| Araxone | Ceftriaxone | 250 mg | Injection | 1s | 062945 | PKR 167.31 | PKR 167.31/vial/unit | 🔒 Pharma Pro |
| Araxone | Ceftriaxone | 500 mg | Injection | 1s | 062946 | PKR 304.74 | PKR 304.74/vial/unit | 🔒 Pharma Pro |
| Araxone | Ceftriaxone | 1 g | Injection | 1s | 062947 | PKR 531.72 | PKR 531.72/vial/unit | 🔒 Pharma Pro |
| Araxone | Ceftriaxone | 2 g | Injection | 1s | 098215 | PKR 745.41 | PKR 745.41/vial/unit | 🔒 Pharma Pro |
| Arepine | Quetiapine | 100 mg | Tablet | 10's | 116414 | PKR 646.23 | PKR 64.62/tablet | 🔒 Pharma Pro |
| Arepine | Quetiapine | 25 mg | Tablet | 30's | 116417 | PKR 646.23 | PKR 21.54/tablet | 🔒 Pharma Pro |
| Arepine | Quetiapine | 25 mg | Tablet | 10's | 116417 | PKR 215.41 | PKR 21.54/tablet | 🔒 Pharma Pro |
| Arepine | Quetiapine | 25 mg | Tablet | 20's | 116417 | PKR 430.82 | PKR 21.54/tablet | 🔒 Pharma Pro |
| Arepine XR | Quetiapine | 300 mg | Tablet | 10's | 116415 | PKR 1,395.85 | PKR 139.59/tablet | 🔒 Pharma Pro |
| Arepine XR | Quetiapine | 150 mg | Extended-release tablet | 10's | 116416 | PKR 837.94 | PKR 83.79/tablet | 🔒 Pharma Pro |
| Arixime | Cefixime | 200 mg | Capsule | 1x5s | 062960 | PKR 273.32 | PKR 54.66/capsule | 🔒 Pharma Pro |
| Arixime | Cefixime | 200 mg | Capsule | 1x10s | 062960 | PKR 518.48 | PKR 51.85/capsule | 🔒 Pharma Pro |
| Arixime | Cefixime | 400 mg | Capsule | 1x5s | 062961 | PKR 538.35 | PKR 107.67/capsule | 🔒 Pharma Pro |
| Arixime | Cefixime | 100 mg/5 mL | Dry suspension | 30ml | 062962 | PKR 298.16 | PKR 9.94/mL | 🔒 Pharma Pro |
| Arixime | Cefixime | 200 mg/5 mL | Dry suspension | 30ml | 062963 | PKR 537.76 | PKR 17.93/mL | 🔒 Pharma Pro |
| Armutine | Acetylcysteine | 200 mg | Sachet | 30's | 116425 | PKR 581.61 | PKR 19.39/sachet | 🔒 Pharma Pro |
| Aromep | Omeprazole | 20 mg | Capsule | 14s | 079576 | PKR 238.53 | PKR 17.04/capsule | 🔒 Pharma Pro |
| Aromep | Omeprazole | 40 mg | Capsule | 14s | 079577 | PKR 414.13 | PKR 29.58/capsule | 🔒 Pharma Pro |
| Aromep | Omeprazole | 40 mg | Injection | 1s | 111840 | PKR 403.85 | PKR 403.85/vial/unit | 🔒 Pharma Pro |
| Calciderm | Calcipotriol | 0.005% | Ointment | 30g | 079488 | PKR 1,192.03 | PKR 39.73/g | 🔒 Pharma Pro |
| Co-flon | Olanzapine + Fluoxetine | 6 mg + 25 mg | Capsule | 14s | 098197 | PKR 390.77 | PKR 27.91/capsule | 🔒 Pharma Pro |
| Co-flon | Olanzapine + Fluoxetine | 3 mg + 25 mg | Capsule | 14s | 098206 | PKR 233.04 | PKR 16.65/capsule | 🔒 Pharma Pro |
| Co-flon | Olanzapine + Fluoxetine | 12 mg + 25 mg | Capsule | 10s | 098207 | PKR 466.06 | PKR 46.61/capsule | 🔒 Pharma Pro |
| Contrazole | Fluconazole | 150 mg | Capsule | 1x1s | 079469 | PKR 247.37 | PKR 247.37/capsule | 🔒 Pharma Pro |
| Contrazole | Fluconazole | 50 mg/5 mL | Dry suspension | 35ml | 079475 | PKR 347.87 | PKR 9.94/mL | 🔒 Pharma Pro |
| Contrazole | Fluconazole | 200 mg | Capsule | 4s | 098213 | PKR 860.41 | PKR 215.10/capsule | 🔒 Pharma Pro |
| Electrofix | Sodium chloride | 13.5 g | Sachet | 20s | 079481 | PKR 496.62 | PKR 24.83/sachet | No comparator |
| Esitil | Escitalopram | 10 mg | Tablet | 1x14s | 079466 | PKR 644.98 | PKR 46.07/tablet | 🔒 Pharma Pro |
| Esitil | Escitalopram | 10 mg | Tablet | 1x10s | 079466 | PKR 460.70 | PKR 46.07/tablet | 🔒 Pharma Pro |
| Esitil | Escitalopram | 20 mg | Tablet | 28s | 098196 | PKR 1,277.18 | PKR 45.61/tablet | 🔒 Pharma Pro |
| Esitil | Escitalopram | 20 mg | Tablet | 14s | 098196 | PKR 766.31 | PKR 54.74/tablet | 🔒 Pharma Pro |
| Ferochel | Deferasirox | 500 mg | Dispersible tablet | 28s | 092080 | PKR 12,397.14 | PKR 442.76/tablet | 🔒 Pharma Pro |
| Fetaclom | Clomifene citrate | 50 mg | Tablet | 10s | 099215 | PKR 357.80 | PKR 35.78/tablet | 🔒 Pharma Pro |
| Glyvanq | Vancomycin | 500 mg | Injection | 1s | 111841 | PKR 1,019.72 | PKR 1,019.72/vial/unit | 🔒 Pharma Pro |
| Glyvanq | Vancomycin | 1 g | Injection | 1s | 111842 | PKR 1,646.13 | PKR 1,646.13/vial/unit | 🔒 Pharma Pro |
| Imucurb | Tacrolimus | 0.5 mg | Capsule | 30s | 092077 | PKR 1,410.00 | PKR 47.00/capsule | 🔒 Pharma Pro |
| Imucurb | Tacrolimus | 0.5 mg | Capsule | 10s | 092077 | PKR 510.87 | PKR 51.09/capsule | 🔒 Pharma Pro |
| Imucurb | Tacrolimus | 1 mg | Capsule | 30s | 092078 | PKR 2,350.00 | PKR 78.33/capsule | 🔒 Pharma Pro |
| Imucurb | Tacrolimus | 1 mg | Capsule | 10s | 092078 | PKR 851.45 | PKR 85.15/capsule | 🔒 Pharma Pro |
All 33 ARP brands in Pakistan
- Antibac-Skin Mupirocin · 2% cream
- Aramox Moxifloxacin · 400 mg tablet
- Arataxime Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Araxone Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Arepine Quetiapine · 100 mg tablet, 25 mg tablet
- Arepine XR Quetiapine · 150 mg tablet, 300 mg tablet
- Arixime Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 200 mg/5 mL suspension
- Armutine Acetylcysteine · 200 mg sachet
- Aromep Omeprazole · 20 mg capsule, 40 mg capsule, 40 mg injection
- Calciderm Calcipotriol · 0.005% ointment
- Co-flon Olanzapine + Fluoxetine · 12 mg + 25 mg capsule, 3 mg + 25 mg capsule, 6 mg + 25 mg capsule
- Contrazole Fluconazole · 150 mg capsule, 200 mg capsule, 50 mg/5 mL suspension
- Electrofix Sodium chloride · 13.5 g sachet
- Esitil Escitalopram · 10 mg tablet, 20 mg tablet
- Ferochel Deferasirox · 500 mg tablet
- Fetaclom Clomifene citrate · 50 mg tablet
- Glyvanq Vancomycin · 1 g injection, 500 mg injection
- Imucurb Tacrolimus · 0.5 mg capsule, 1 mg capsule
- Infecnil Ciprofloxacin · 200 mg/100 mL infusion, 250 mg tablet, 500 mg tablet
- Isoflox Levofloxacin · 250 mg tablet, 500 mg tablet
- Konxol Voriconazole · 200 mg tablet
- Linvox Linezolid · 400 mg tablet, 400 mg/200 mL infusion, 600 mg tablet
- Obsertin Sertraline · 100 mg tablet, 50 mg tablet
- Prevon Tabs Ondansetron · 4 mg tablet, 8 mg tablet
- Purox Cefuroxime · 1.5 g injection, 250 mg injection
- Ramid-4 Rifampicin + Isoniazid + Pyrazinamide + Ethambutol · 150 mg + 75 mg + 400 mg + 275 mg tablet
- Respocure Clarithromycin · 125 mg/5 mL suspension, 250 mg/5 mL suspension
- Retipro Terbinafine · 1 % cream
- Roxidep Paroxetine · 20 mg tablet
- Roxidep CR Paroxetine · 12.5 mg tablet, 25 mg tablet, 37.5 mg tablet
- Symed Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Trespor Itraconazole · 100 mg capsule
- Zitpro Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
ARP: common questions
How many products does ARP have in Pakistan?
ARP (PVT) Limited has 84 registered medicine presentations in Pakistan, sold under 33 brands and covering 31 generic medicines.
What are the main brands of ARP?
By number of registered strengths and packs, its largest brands are Araxone (Ceftriaxone), Arixime (Cefixime), Arepine (Quetiapine), Esitil (Escitalopram) and Imucurb (Tacrolimus). This is not a sales ranking.
Which therapy areas does ARP cover?
The most products are in Anti-infectives (43), CNS & mental health (24), Gastrointestinal & hepatology (7), Oncology & immunology (4) and Dermatology (2).
Where can I see ARP medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.